FindTrial
Sign In

Effect of the drug â??Immuneâ??- an Ayurveda medication in COVID-19 patients

Immunological Effect of the drug â??Immuneâ??- an Ayurveda medication in COVID-19 patients

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/10/028471
Enrollment
50
Registered
2020-10-19
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B972- Coronavirus as the cause of diseases classified elsewhere Health Condition 2: B999- Unspecified infectious disease

Interventions

Intervention1: Immune-combination of Devadaaru, Aswagandha, Yashthimadu and Jeevanthi which are already proven drugs: 6 drops in 50 ml of water every 4 hours Administered for 15 days Control Interve

Sponsors

NGR Vishnu Sri
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Mild to Moderate COVID- 19 confirmed patients of age greater than 20 years and upto 58 years and willing to participate with consent

Exclusion criteria

Exclusion criteria: Who are not willing to participate, with co-morbidities, pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
To detect the rise in antibody titre with the drug intake and reduction in inflammatory markers with the drug intake.Timepoint: 2 months—

Secondary

MeasureTime frame
duration of hospital stayTimepoint: 2 months—

Countries

India

Contacts

Public ContactSailaja Vani

ESIC Medical college, Sanathnagar, Hyderabad

dr.sudhabala78@gmail.com7702031889

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026